StreetAlpha
Bristol Myers Squibb Co · SEC Form 4

BMY Insider Trading

From SEC Form 410 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Bristol Myers Squibb Co stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $2.5M sold.

← BMY stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$2.5M4 sales · 4 insiders
Net−$2.5Mbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJanFebMar2026-04: sold $1.9MAprMayJunJul2026-08: sold $34KAug2026-09: sold $403KSepOct2026-11: sold $241KNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when BMY insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an BMY officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every BMY insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 5, 2026Julia A HallerDirectorSale3,800$63.31$241K30,279Nov 6Form 4
Sep 9, 2026Cristian MassacesiEVP,Chief Med Offr,Head of DevSale6,249$64.57$403K18,748Sep 10Form 4
Aug 25, 2026Phil M HolzerSVP and ControllerSale500$67.50$34K16,862Aug 26Form 4
Apr 1, 2026David V ElkinsEvp, CFOSale30,000$61.67$1.9M159,248Apr 2Form 4
Sep 2, 2025David V ElkinsEvp, CFOSale56,000$47.33$2.7M167,379Sep 3Form 4
Aug 2, 2025Bartie Wendy ShortEVP, Corporate AffairsSale378$44.23$17K5,066Aug 5Form 4
May 9, 2025Benjamin HickeyPresident, RayzeBio Org.Sale97$38.01$4K0May 13Form 4
Apr 25, 2025Samit HirawatEVP,Chief Med.Offr.,Drug Dev.Buy4,250$47.58$202K83,513Apr 29Form 4
Feb 20, 2025Christopher S. BoernerCEOBuy2,000$55.05$110K104,626Feb 21Form 4
Feb 14, 2025Samit HirawatEVP,Chief Med.Offr.,Drug Dev.Buy1,823$54.84$100K63,932Feb 19Form 4

BMY insider trading FAQ

Are BMY insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of BMY on the open market in 0 trades, and 4 sold $2.5M in 4 trades.

When did an BMY insider last buy shares?

Samit Hirawat (EVP,Chief Med.Offr.,Drug Dev.) bought 4,250 shares for $202K on Apr 25, 2025, reported on Apr 29, 2025.

When did an BMY insider last sell shares?

Julia A Haller (Director) sold 3,800 shares for $241K on Nov 5, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice